Narwhal Capital Management cut its stake in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 5.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target hoisted by equities researchers at UBS Group from $162.00 to $176.00 in a research note issued to investors on ...

RBC Capital analyst Kaan Peker maintained a Buy rating on Mineral Resources Limited (MALRF – Research Report) on January 30 and set a price ...

The threat of tariffs has loomed large over U.S. equities. Investors and strategists warn that high levies can reignite ...

US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of ...

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...

Britain’s biggest supermarket chain used data to gain an edge, but as rivals start to catch up, Michael Fahy looks at whether its growth prospects are worth buying into ...

That helps underscore UBS analyst Joseph Spak's belief that investors don't really view Tesla (TSLA) as a carmaker any more. "We can almost definitively say the market doesn't treat TSLA like an auto ...

UBS implements Azure-based assistant to 30,000 staff in Asian and European booking centres through enterprise-scale ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...